Skip to main content

Table 2 Literature review for oncologic imaging or phantom studies with positron emission tomography

From: Radiomics in medical imaging—“how-to” guide and critical reflection

 

Ref.

Study (first author)

Year

Factor

Site/Organ

Test-retest

[77]

Konert et al.

2020

 

NSCLC

[78]

Vuong et al.

2019

 

Lung cancer

[79]

Gallivanone et al.

2018

 

Phantom

[40]

Desseroit et al.

2017

 

NSCLC

[80]

Leijenaar et al.

2013

 

NSCLC

Acquisition

[77]

Konert et al.

2020

Breathing

NSCLC

[81]

Pfaehler et al.

2019

Acquisition time

Phantom

[82]

Branchini et al.

2019

Injected activity

Pedriatic cancer

[78]

Vuong et al.

2019

Breathing

Lung cancer

[83]

Charles et al.

2017

Breathing

Phantom

[84]

Lovat et al.

2017

Scan timing

Neurofibromatosis-1

[85]

Reuzé et al.

2017

Scanner

Cervical cancer

[86]

Shiri et al.

2017

Acquisition time

Phantom, lung, HN, liver cancer

[13]

Bailly et al.

2016

Acquisition time

Neuroendocrine tumors

[87]

Forgacs et al.

2016

Acquisition time

Phantom, lung cancer

[88]

Grootjans et al.

2016

Breathing, duty cycle

Lung cancer

[89]

Nyflot et al.

2015

Injected activity, acquisiton time

Simulated phantom

Reconstruction

[81]

Pfaehler et al.

2019

Algorithm, PSF, FWHM

Phantom

[79]

Gallivanone et al.

2018

PSF, TOF, matrix size, iterations, subsets, FWHM

Phantom

[12]

Altazi et al.

2017

Algorithm

Cervical tumor

[86]

Shiri et al.

2017

PSF, TOF, iterations, subsets, FWHM, matrix size

Phantom, lung, HN, liver cancer

[13]

Bailly et al.

2016

Algorithm, iterations, FWHM, matrix size

Neuroendocrine tumors

[90]

Cheng et al.

2016

Attenuation correction

NSCLC

[87]

Forgacs et al.

2016

Algorithm, TOF, FWHM, voxel size

Phantom, lung cancer

[91]

Lasnon et al.

2016

PSF, FWHM

Lung cancer

[92]

van Velden et al.

2016

Algorithm

NSCLC

[93]

Doumou et al.

2015

FWHM

Esophageal cancer

[89]

Nyflot et al.

2015

Iterations, FWHM

Phantom

[94]

Yan et al.

2015

PSF, TOF, iterations, FWHM, matrix size

Lung cancer

Segmentation

[77]

Konert et al.

2020

 

NSCLC

[95]

Yang et al.

2020

 

Simulated lung lesions

[81]

Pfaehler et al.

2019

 

Phantom

[78]

Vuong et al.

2019

 

Lung cancer

[79]

Gallivanone et al.

2018

 

Phantom

[96]

Hatt et al.

2018

 

NSCLC, HN, simulated lesions

[12]

Altazi et al.

2017

 

Cervical tumor

[83]

Charles et al.

2017

 

Phantom

[97]

Lu et al.

2016

 

Nasopharyngeal carcinoma

[92]

van Velden et al.

2016

 

NSCLC

[93]

Doumou et al.

2015

 

Esophageal cancer

[98]

Hatt et al.

2013

 

Esophageal cancer

[80]

Leijenaar et al.

2013

 

NSCLC

Image processing

[77]

Konert et al.

2020

Discretization

NSCLC

[95]

Yang et al.

2020

Discretization

Simulated lung lesions

[82]

Branchini et al.

2019

Discretization

Pedriatic cancer

[87]

Forgacs et al.

2019

Discretization

Lung cancer

[81]

Pfaehler et al.

2019

Discretization

Phantom

[99]

Whybra et al.

2019

Resampling

Esophageal cancer

[100]

Presotto et al.

2018

Discretization

Phantom

[12]

Altazi et al.

2017

Discretization

Cervical cancer

[85]

Reuzé et al.

2017

Resampling

Cervical cancer

[101]

Yip et al.

2017

Discretization, resampling

NSCLC

[97]

Lu et al.

2016

Discretization

Nasopharyngeal carcinoma

[92]

van Velden et al.

2016

Discretization

NSCLC

[93]

Doumou et al.

2015

Discretization

Esophageal cancer

[14]

Leijenaar et al.

2015

Discretization

NSCLC